pipette
ESEspañol

Patents on Small-Molecule Drugs Approved by the US Food and Drug Administration, 1990-2019

S. Sean Tu, Nickolas Freeman, Theodore W. Teng, William B. Feldman, Aaron Seth Kesselheim, Jason Parton, Olivier J. Wouters

Peer-reviewed journalReal-world useEasy to read

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
These portfolios have largely been built on nonprimary patents, which are then enforced against generic firms at higher rates than primary patents.

Appeared: Wednesday, September 30. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.16139